Mayfair Advisory Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $380K | Sell |
1,917
-83
| -4% | -$16.4K | 0.18% | 106 |
|
|
2025
Q1 | $419K | Buy |
2,000
+280
| +16% | +$58.7K | 0.24% | 80 |
|
|
2024
Q4 | $306K | Buy |
1,720
+100
| +6% | +$17.8K | 0.18% | 105 |
|
|
2024
Q3 | $315K | Hold |
1,620
| – | – | 0.2% | 98 |
|
|
2024
Q2 | $276K | Hold |
1,620
| – | – | 0.19% | 108 |
|
|
2024
Q1 | $295K | Buy |
1,620
+100
| +7% | +$18.2K | 0.21% | 100 |
|
|
2023
Q4 | $243K | Hold |
1,520
| – | – | 0.21% | 104 |
|
|
2023
Q3 | $226K | Hold |
1,520
| – | – | 0.22% | 107 |
|
|
2023
Q2 | $206K | Hold |
1,520
| – | – | 0.21% | 117 |
|
|
2023
Q1 | $246K | Buy |
1,520
+37
| +2% | +$5.98K | 0.27% | 94 |
|
|
2022
Q4 | $240K | Buy |
+1,483
| New | +$240K | 0.31% | 92 |
|
|
2022
Q2 | – | Sell |
-1,350
| Closed | -$220K | – | 118 |
|
|
2022
Q1 | $220K | Buy |
+1,350
| New | +$220K | 0.28% | 98 |
|
|
2021
Q4 | – | Sell |
-2,017
| Closed | -$219K | – | 99 |
|
|
2021
Q3 | $219K | Hold |
2,017
| – | – | 0.34% | 85 |
|
|
2021
Q2 | $227K | Hold |
2,017
| – | – | 0.36% | 79 |
|
|
2021
Q1 | $219K | Sell |
2,017
-43
| -2% | -$4.67K | 0.39% | 77 |
|
|
2020
Q4 | $221K | Buy |
+2,060
| New | +$221K | 0.43% | 73 |
|